The Food and Drug Administration (FDA) yesterday said that there is a temporary supply shortage of Artelac eye drops, as demand for the product increased after another brand withdrew from National Health Insurance (NHI) coverage.
Pharmacist Shen Tsai-ying (沈采穎), a Chinese Nationalist Party legislative-at-large nominee, on Tuesday wrote on her Facebook page: “There is a big shortage of Artelac eye drops. Does everyone know it is caused by the National Health Insurance Administration [NHIA]?”
FDA Deputy Director Cheng Hwei-fang (陳惠芳) yesterday said the NHI-covered Artelac eye drops contain active ingredient hydroxypropyl methylcellulose and are used to temporarily relieve burning, irritation and discomfort caused by dry eyes.
Photo: CNA
The FDA on Jan. 13 last year received a report from the pharmaceutical company saying that due to the shortage of packaging material and ingredients, it would not be able to provide sufficient amounts of the eye drops, Cheng said.
The company imported extra amounts — about seven months’ worth — of eye drops in October last year, but as another brand of eye drops named Tears Naturale with the same active ingredient withdrew from NHI system, there has been a shortage, Cheng said.
FDA Medicinal Products Section senior specialist Yang Bo-wen (楊博文) said before the other brand withdrew from NHI coverage, in one month about 40,000 bottles of Artelac eye drops used to be prescribed under NHI coverage.
Yang said the pharmaceutical company plans to import another batch in April, which should help the supply situation.
In the meantime, while there is a temporary shortage, people who need eye drops are advised to purchase alternative drugs with the same active ingredient and dosage form, but in different sizes, including the NHI-covered Wu-Fu Artificial Tear (五福滴視點眼液), or self-paid Min Young Lubricant Eye Drops (明漾人工淚液點眼液), Chen said.
Separately, the NHIA yesterday said Artelac eye drops are classified as an instruction drug (instructed by physicians, pharmacists or assistant pharmacists) for relieving discomfort caused by dry eyes.
There are 17 types of drugs with the same indications covered by the NHI, including one with the same active ingredient and dosage form, so physicians can instruct people to use the alternative drugs based on their needs, it said.
Regarding Tears Naturale’s withdrawal from the NHI, the NHIA said it has negotiated with the company several times, but the company expressed its wish to withdraw due to a business strategy adjustment.
After two NHI drug coverage and reimbursement criteria meetings, they agreed that it is an instruction drug that is not irreplaceable and should be allowed to return to the self-paid market, the NHIA said, adding that according to the National Health Insurance Act (全民健康保險法), the NHI does not cover the drug anymore.
RESOLUTIONS DEBATE: Taiwan’s allies said that UN and WHA resolutions cited by China and other nations ‘do not determine Taiwan’s participation in WHO activities’ A proposal to invite Taiwan to this year’s World Health Assembly (WHA) was rejected on Monday, resulting in Taipei’s absence from the annual meeting for a ninth consecutive year, although partners spoke up for Taiwan’s participation at the first day of the meeting. The first agenda item after the opening was a “two-on-two debate” on a proposal to invite Taiwan to participate at the WHA as an observer. Similar to previous years, two countries made statements in favor of the proposal, while two others expressed their opposition. Philippine Secretary of Health Teodoro Herbosa, president of the 78th WHA, accepted the WHA General Committee’s
Palauan President Surangel Whipps Jr arrived in Taiwan last night to kick off his first visit to the country since beginning his second term earlier this year. After arriving at Taoyuan International Airport at around 6:30 pm, Whipps and his delegation were welcomed by Minister of Foreign Affairs Lin Chia-lung (林佳龍). Speaking to gathered media, the Palauan leader said he was excited and honored to be back in Taiwan on his first state visit to Taiwan since he was sworn in this January. Among those traveling with Whipps is Minister of State Gustav N. Aitaro, Public Infrastructure
Premier Cho Jung-tai (卓榮泰) on Friday laid out the Cabinet’s updated policy agenda and recapped the government’s achievements ahead of the one-year anniversary of President William Lai’s (賴清德) inauguration. Cho said the government had made progress across a range of areas, including rebuilding Hualien, cracking down on fraud, improving pedestrian safety and promoting economic growth. “I hope the public will not have the impression that the Cabinet only asked the legislature to reconsider a bunch of legal amendments,” Cho said, calling the moves “necessary” to protect constitutional governance and the public’s interest. The Cabinet would work toward achieving its “1+7” plan, he said. The
Nvidia founder and CEO Jensen Huang (黃仁勳) hosted a dinner in Taipei last night with key Taiwanese suppliers to celebrate the successful mass production of the company’s new Blackwell AI systems. Speaking to the media earlier yesterday, Huang thanked Nvidia’s Taiwanese partners for their contributions to the company’s ecosystem, while also sharing his plans to meet with Taiwan Semiconductor Manufacturing Co (TSMC) founder Morris Chang (張忠謀). In response to rumors that Nvidia will launch a downgraded Hopper H20 chip for China in July, Huang dismissed the reports, saying, “That is not true.” He clarified that there
RSS